Yoshio Nakamura

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma.

Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma.

Journal: Melanoma research

Published: June 02, 2026

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Journal: BMC cancer

Published: January 27, 2026

A case of disseminated and chronic varicella zoster virus infection with persistent ulcer formation in a rheumatoid vasculitis patient treated with immunosuppressants.

A case of disseminated and chronic varicella zoster virus infection with persistent ulcer formation in a rheumatoid vasculitis patient treated with immunosuppressants.

Journal: JAAD case reports

Published: October 27, 2025

Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025.

Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Basal Cell Carcinoma 2025.

Journal: The Journal of dermatology

Published: October 17, 2025

Sarcoid Vasculitis in the Skin: A Clinicopathologic Study of 8 Cases With Various Skin Lesions but the Common Unique Cannonball-like Vessel Destruction by Sarcoid Granulomas.

Sarcoid Vasculitis in the Skin: A Clinicopathologic Study of 8 Cases With Various Skin Lesions but the Common Unique Cannonball-like Vessel Destruction by Sarcoid Granulomas.

Journal: The American journal of surgical pathology

Published: November 27, 2024

IgA vasculitis presenting with Achilles peritendinitis: A case report.

IgA vasculitis presenting with Achilles peritendinitis: A case report.

Journal: The Journal of dermatology

Published: September 02, 2024

Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.

Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.

Journal: The Journal of dermatology

Published: June 09, 2024

Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).

Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).

Journal: The oncologist

Published: February 16, 2024

Identification of a rare MET variant in three siblings with extramammary Paget disease.

Identification of a rare MET variant in three siblings with extramammary Paget disease.

Journal: Clinical and experimental dermatology

Published: December 07, 2023

Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis.

Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis.

Journal: Experimental dermatology

Published: November 11, 2023

A case of cutaneous chromoblastomycosis in a toddler due to Verticillium spp. identified by molecular biological methods from formalin-fixed and paraffin-embedded samples.

A case of cutaneous chromoblastomycosis in a toddler due to Verticillium spp. identified by molecular biological methods from formalin-fixed and paraffin-embedded samples.

Journal: The Journal of dermatology

Published: September 21, 2023

Negative differential resistance based on phase transformation.

Negative differential resistance based on phase transformation.

Journal: Materials horizons

Published: September 13, 2023

Showing 1-12 of 59

Last Updated: 09/26/2026